Crossref
Prehospital Tranexamic Acid Does Not Improve Disability Outcomes
JAMA · 2023
DOI: 10.1001/jama.2023.10740 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Antifibrinolytic Agents, Emergency Medical Services, Shock, Hemorrhagic, Tranexamic Acid.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Antifibrinolytic AgentsEmergency Medical ServicesShock, HemorrhagicTranexamic AcidHumansTreatment Outcome
Substanzen
Antifibrinolytic AgentsTranexamic Acid
Zitieren
APA
Harris, E. (2023). Prehospital Tranexamic Acid Does Not Improve Disability Outcomes. JAMA. https://doi.org/10.1001/jama.2023.10740
Vancouver
Harris E. Prehospital Tranexamic Acid Does Not Improve Disability Outcomes. JAMA. 2023. doi:10.1001/jama.2023.10740
BibTeX
@article{Harris2023,
author = {Harris, Emily},
title = {Prehospital Tranexamic Acid Does Not Improve Disability Outcomes},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.10740}
}
EUVIMED